Matches in SemOpenAlex for { <https://semopenalex.org/work/W2526853173> ?p ?o ?g. }
Showing items 1 to 60 of
60
with 100 items per page.
- W2526853173 abstract "TPS10585Background: Pembro, a highly selective humanized monoclonal antibody that directly blocks the interaction between programmed death 1 (PD-1) and its ligands PD-L1 and PD-L2, is indicated for..." @default.
- W2526853173 created "2016-10-07" @default.
- W2526853173 creator A5005775401 @default.
- W2526853173 creator A5017501517 @default.
- W2526853173 creator A5034507901 @default.
- W2526853173 creator A5046880941 @default.
- W2526853173 creator A5050023628 @default.
- W2526853173 creator A5050738935 @default.
- W2526853173 creator A5051922909 @default.
- W2526853173 creator A5072028799 @default.
- W2526853173 creator A5085820190 @default.
- W2526853173 date "2016-05-20" @default.
- W2526853173 modified "2023-09-27" @default.
- W2526853173 title "Phase 1/2 study of pembrolizumab (pembro) in children with advanced melanoma or a PD-L1-positive (PD-L1+) advanced, relapsed, or refractory solid tumor or lymphoma (KEYNOTE-051)." @default.
- W2526853173 doi "https://doi.org/10.1200/jco.2016.34.15_suppl.tps10585" @default.
- W2526853173 hasPublicationYear "2016" @default.
- W2526853173 type Work @default.
- W2526853173 sameAs 2526853173 @default.
- W2526853173 citedByCount "0" @default.
- W2526853173 crossrefType "journal-article" @default.
- W2526853173 hasAuthorship W2526853173A5005775401 @default.
- W2526853173 hasAuthorship W2526853173A5017501517 @default.
- W2526853173 hasAuthorship W2526853173A5034507901 @default.
- W2526853173 hasAuthorship W2526853173A5046880941 @default.
- W2526853173 hasAuthorship W2526853173A5050023628 @default.
- W2526853173 hasAuthorship W2526853173A5050738935 @default.
- W2526853173 hasAuthorship W2526853173A5051922909 @default.
- W2526853173 hasAuthorship W2526853173A5072028799 @default.
- W2526853173 hasAuthorship W2526853173A5085820190 @default.
- W2526853173 hasConcept C121608353 @default.
- W2526853173 hasConcept C126322002 @default.
- W2526853173 hasConcept C142424586 @default.
- W2526853173 hasConcept C143998085 @default.
- W2526853173 hasConcept C191897082 @default.
- W2526853173 hasConcept C192562407 @default.
- W2526853173 hasConcept C2777701055 @default.
- W2526853173 hasConcept C2780057760 @default.
- W2526853173 hasConcept C2781053074 @default.
- W2526853173 hasConcept C2993640289 @default.
- W2526853173 hasConcept C502942594 @default.
- W2526853173 hasConcept C71924100 @default.
- W2526853173 hasConceptScore W2526853173C121608353 @default.
- W2526853173 hasConceptScore W2526853173C126322002 @default.
- W2526853173 hasConceptScore W2526853173C142424586 @default.
- W2526853173 hasConceptScore W2526853173C143998085 @default.
- W2526853173 hasConceptScore W2526853173C191897082 @default.
- W2526853173 hasConceptScore W2526853173C192562407 @default.
- W2526853173 hasConceptScore W2526853173C2777701055 @default.
- W2526853173 hasConceptScore W2526853173C2780057760 @default.
- W2526853173 hasConceptScore W2526853173C2781053074 @default.
- W2526853173 hasConceptScore W2526853173C2993640289 @default.
- W2526853173 hasConceptScore W2526853173C502942594 @default.
- W2526853173 hasConceptScore W2526853173C71924100 @default.
- W2526853173 hasLocation W25268531731 @default.
- W2526853173 hasOpenAccess W2526853173 @default.
- W2526853173 hasPrimaryLocation W25268531731 @default.
- W2526853173 isParatext "false" @default.
- W2526853173 isRetracted "false" @default.
- W2526853173 magId "2526853173" @default.
- W2526853173 workType "article" @default.